Analysis on the Correlation Between RUNX3 Mislocalization and Epigenetic Parameters in Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, W. [1 ,2 ]
Huang, C. [1 ,3 ]
Shi, Y. [4 ,5 ]
Lu, J. [4 ]
Chen, X. [1 ,2 ,5 ]
机构：
[1] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Thorac Surg, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Oncol Sch, Lab Immunooncol, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Clin Oncol Sch, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
runt-related transcription factor 3; promoter hypermethylation; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.02B.06
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [41] Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series
    Ahmed, Tahreem
    Vial, Macarena R.
    Ost, David
    Stewart, John
    Hasan, Muhammad A.
    Grosu, Horiana B.
    LUNG CANCER, 2018, 122 : 220 - 223
  • [42] Genetic and Epigenetic Alterations are Associated with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Cai, L.
    Bai, H.
    Wang, Z.
    Wang, S.
    Duan, J.
    Gao, S.
    He, J.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [43] SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
    Taguchi, Y-h
    Iwadate, Mitsuo
    Umeyama, Hideaki
    BMC MEDICAL GENOMICS, 2016, 9
  • [44] Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies
    Carter, Corey A.
    Zeman, Karen
    Day, Regina M.
    Richard, Patrick
    Oronsky, Arnold
    Oronsky, Neil
    Lybeck, Michelle
    Scicinski, Jan
    Oronsky, Bryan
    ONCOTARGET, 2016, 7 (26) : 40781 - 40791
  • [45] The Role of STAT3 in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    Kiura, Katsuyuki
    CANCERS, 2014, 6 (02): : 708 - 722
  • [46] A preliminary analysis of non-small cell lung cancer biomarkers in serum
    Xiao, XY
    Tang, Y
    Wei, XP
    He, DC
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2003, 16 (02) : 140 - 148
  • [47] Whole genome microarray analysis in non-small cell lung cancer
    AL Zeyadi, Mohammad
    Dimova, Ivanka
    Ranchich, Vladislav
    Rukova, Blaga
    Nesheva, Desislava
    Hamude, Zora
    Georgiev, Sevdalin
    Petrov, Danail
    Toncheva, Draga
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2015, 29 (01) : 111 - 118
  • [48] Analysis of the response and toxicity to gefitinib of non-small cell lung cancer
    Konishi, J
    Yamazaki, K
    Kinoshita, I
    Isobe, H
    Ogura, S
    Sekine, S
    Ishida, T
    Takashima, R
    Nakadate, M
    Nishikawa, S
    Hattori, T
    Asahina, H
    Imura, M
    Kikuchi, E
    Kikuchi, J
    Shinagawa, N
    Yokouchi, H
    Munakata, M
    Dosaka-Akita, H
    Nishimura, M
    ANTICANCER RESEARCH, 2005, 25 (1B) : 435 - 441
  • [49] A Preliminary Analysis of Non-small Cell Lung Cancer Biomarkers in Serum
    XUE-YUAN XIAO#
    Beijing Tiantan Hospital
    Biomedical and Environmental Sciences, 2003, (02) : 140 - 148
  • [50] Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer
    Hames, Megan L.
    Chen, Heidi
    Iams, Wade
    Aston, Jonathan
    Lovly, Christine M.
    Horn, Leora
    LUNG CANCER, 2016, 92 : 29 - 34
12345